Back to Top Skip to main content

Antibiotic resistance a serious threat that's growing, CDC warns

A bacteriology researcher at the Institute of Medical Research swabs an isolated sample of streptococcus pneumonia in Goroka, Papua New Guinea, June 4, 2015. The researcher is testing the bacteria to determine if the strain has sensitivity to antibiotics or if it is resistant.  (U.S. Air Force photo by Staff Sgt. Marcus Morris/Released) A bacteriology researcher at the Institute of Medical Research swabs an isolated sample of streptococcus pneumonia in Goroka, Papua New Guinea. The researcher is testing the bacteria to determine if the strain has sensitivity to antibiotics or if it is resistant. (U.S. Air Force photo by Staff Sgt. Marcus Morris)

Recommended Content:

Conditions and Treatments | Public Health

Doctors prescribe sick patients antibiotic drugs with the specific intent of knocking out the viral, bacterial or fungal infections that put them under the weather. But new research shows microbial pests have learned to fight back.

During a Nov. 13 telephone briefing for news media, both Dr. Robert R. Redfield, the director of the Centers for Disease Control and Prevention (CDC), and Michael Craig of the agency’s Antibiotic Resistance Coordination and Strategy Unit, outlined the situation at hand. Each year, more than 2.8 million infections related to antibiotic resistance take place. More than 35,000 people die from those infections.

Redfield and Craig spoke of the CDC’s newly published white paper on the subject, which reports that nearly 3 million Americans “face an antibiotic-resistant infection.”

The report, titled "Antibiotic Resistance Threats in the United States," identifies 18 known antibiotic-resistant pathogens that must be dealt with before they can proliferate and spread untreatable illnesses. The latest statistics, Redford and Craig said, indicate the problem is far more serious than researchers believed when they prepared the last such report in 2013. Improved measuring methodology has shown that the number of deaths back then was actually twice as high as they believed at the time.

“CDC uses the best data, but [estimates were] conservative at the time,” Craig said.

“It threatens our nation’s health and our global security,” Redfield said. “The good news is we know how to protect ourselves. We’re seeing progress nationwide.”

Related hospital deaths have declined by 18 percent overall and by 30 percent in hospitals alone, Redford said, through the implementation of comprehensive strategies throughout the human and animal health-care professions and agriculture as well. 

The CDC is taking a five-pronged approach toward a solution. It entails: infection prevention and control; tracking and sharing data; improving the appropriate use of antibiotics; investment in vaccines, therapeutics and diagnostics; and close monitoring of the environment and sanitation practices.

Within the Military Health System, and particularly at the Uniformed Services University of the Health Sciences, researchers are also taking the issue of antimicrobial resistance seriously.

“Over the last few years we have actively been studying the epidemiology and the outcomes associated with antimicrobial resistance infections in military hospitals,” explained Dr. Allison Malloy, assistant professor and infectious disease faculty, Department of Pediatrics, USU. “Consistent with the CDC findings, we have found a high mortality associated with some of these infections.  Across the Department of Defense facilities, we have implemented programs to help control these infections including active surveillance, rapid pathogen identification and targeted treatment, and data-driven antibiotic stewardship programs.”

For example, the Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), under the Walter Reed Army Institute of Research, coordinates analysis and management of antibiotic resistance across the entire military health system. This helps military treatment facilities share information, optimize standard practices for infection control and patient safety, identify an outbreak of a pathogen earlier, and make more appropriate antibiotic selections for patients.  MRSN is part of a DoD-wide effort, Antimicrobial Resistance and Monitoring Research Program (ARMoR), which includes DoD hospital laboratories, clinicians and infection control staff; public health reporting groups; Navy and Air Force public health data collection programs; and national policy groups, with the common goal of managing Service programs monitoring antibiotic-resistant bacteria.

“We will continue to monitor for infections and seek to improve the quality of healthcare provided to military members, their families and retirees,” Dr. Malloy said.

While medical community researchers and clinicians are taking action to counter the bad effects of antibiotic resistance, the CDC offered practical advice that would help average citizens mitigate the risks they face. Here are some:

  • When visiting a doctor to treat sickness, ask what could make you feel better rather than request antibiotics specifically. If prescribed antibiotics, use them in the manner in which your provider asks.
  • Follow good hygiene practices. Wash your hands, be careful when handling food or caring for animals.
  • Get vaccinated.
  • Practice safe sex.
  • Be vigilant when traveling abroad.

Health care providers can do their part as well, the report said, by following good infection prevention and control practices and being more vigilant when prescribing antibiotics. Providers also should take note of infections and resistance patterns where they work and in their communities.

You also may be interested in...

DHA PI 6025.14: Active Duty Service Member (ADSM) Erythrocyte Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Sickle Cell Trait (SCT) Screening

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (o), establishes Defense Health Agency’s (DHA) procedures to implement Reference (d), for erythrocyte G6PD deficiency and SCT screening at the appropriate points: during entry to the Military Services (at appointment, enlistment, or induction (Reference (j)), at pre-deployment, and at other points as indicated for validation of results (per References (k), (m), and (n)).

DoD Instruction 6490.13: Comprehensive Policy on Traumatic Brain Injury-Related Neurocognitive Assessments by the Military Services

Policy

This instruction establishes policy, assigns responsibilities, and prescribes standard elements, pursuant to section 722 of Public Law 111-383, requiring the implementation of a comprehensive neurocognitive assessment policy in the Military Services.

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

Pre-Deployment, Deployment, and Post-Deployment Training, Screening, and Monitoring Guidance for Department of Defense Personnel Deployed to Ebola Outbreak Areas

Policy

Department of Defense (DoD) personnel (Service members and civilian employees)deployed to Centers for Disease Control and Prevention defined Ebola outbreak areas will complete pre and post-deployment screening and training requirements outlined in this memorandum and supplemented by United States Africa Command (USAFRICOM) guidance.

Influenza Surveillance Program

Policy

Sentinel Sites for the 2014-2015 Influenza Surveillance Program

Deployment Limiting Mental Disorders and Psychotrophic Medications

Policy

Policy memorandum about Deployment Limiting Mental Disorders and Psychotrophic Medications

DoD Instruction Number 6490.11: DoD Policy Guidance for Management of Mild Traumatic Brain Injury/Concussion in the Deployed Setting

Policy

This instruction establishes policy, assigns responsibilities, and provides procedures on the management of mild traumatic brain injury (mTBI), also known as concussion, in the deployed setting.

Access to Medical Services Who were Exposed to Rabies in Combat Theater

Policy

U.S. Navy/U.S. Marine Corps COSC Policy Update

Policy

Mental Health Assessments for Members of the Armed Forces Deployed in Connection with a Contingency Operation

Policy

Clinical Policy for the Administration of the Anthrax Vaccine Adsorbed

Policy

DoD Directive 6490.5 on Combat Stress Control Programs

Policy
Showing results 1 - 12 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.